Meprobamate

Sold as Miltown, Equanil, Meprospan, Meprobamate, Neuramate and 2 more. Every FDA application for this active ingredient: 19 branded and 38 generic.

As of Nov 13, 2026, FDA lists 57 applications for Meprobamate (sold as Miltown, Equanil, Meprospan and others), first approved Apr 28, 1955, with 0 new uses approved and 0 published complete response letters.

First approved: Apr 28, 1955
Applications: 57
New uses approved: 0
Complete response letters: 0
Medicare spending, 2025: $1.1M

Medicare Spending

CMS Part D and Part B, 2025, before manufacturer rebates; matched by generic name

Product	Part	Spending, 2025	Change	Beneficiaries
Meprobamate	Part D	$1.1M	-2%	559

Applications

NDAs, BLAs and generic ANDAs for this ingredient, oldest first; each opens its full history


Apr 28, 1955	MiltownNDA 9698 · New formulation or manufacturer	Medpointe Pharm Hlc	13	Discontinued
Jul 26, 1955	EquanilNDA 10028 · New molecular entity	Wyeth Ayerst	11	Discontinued
Jul 3, 1963	NeuramateNDA 14359 · New formulation or manufacturer	Halsey	30	Discontinued
Jul 26, 1963	MeprobamateNDA 14547 · New formulation or manufacturer	Sandoz	6	Discontinued
Aug 9, 1963	MeprobamateNDA 14882 · New formulation or manufacturer	Chartwell Molecular	6	Discontinued
Apr 13, 1964	MeprobamateNDA 15072 · New formulation or manufacturer	Mallard	0	Discontinued
Dec 12, 1964	MeprobamateNDA 15417 · New formulation or manufacturer	West Ward	2	Discontinued
Jan 27, 1967	TranmepNDA 16249 · New formulation or manufacturer	Solvay	11	Discontinued
Jul 29, 1971	BamateANDA 80380	Alra	0	Discontinued
Jul 12, 1972	MeprobamateANDA 80655	Rising	19	Discontinued
Oct 16, 1972	MeprobamateANDA 80699	Sun Pharm Industries	10	Discontinued
Apr 23, 1973	MeprobamateANDA 83304	Watson Labs	12	Discontinued
May 3, 1973	MeprobamateANDA 83308	Watson Labs	14	Discontinued
Dec 20, 1973	MeprobamateANDA 83442	Whiteworth Town Plsn	0	Discontinued
Jan 28, 1974	MiltownANDA 83919	Medpointe Pharm Hlc	5	Discontinued
Feb 13, 1974	MeprobamateANDA 83830	Whiteworth Town Plsn	1	Discontinued
Apr 29, 1974	MeprobamateANDA 84181	Ivax Sub Teva Pharms	0	Discontinued
May 10, 1974	AmoseneANDA 84030	Ferndale Labs	0	Discontinued
Jul 3, 1974	MeprobamateANDA 84153	Acella	4	Discontinued
Jul 10, 1974	MeprobamateANDA 84230	Barr	0	Discontinued
Sep 30, 1974	MeprobamateANDA 84220	Nexgen Pharma Inc	0	Discontinued
Apr 17, 1975	MeprobamateANDA 84589	Nexgen Pharma Inc	0	Discontinued
Dec 9, 1975	MeprobamateANDA 84744	Parke Davis	0	Discontinued
Nov 11, 1976	MeprobamateANDA 84274	Watson Labs	2	Discontinued
Jul 13, 1977	MeprobamateANDA 85719	Watson Labs	1	Discontinued
Jul 13, 1977	MeprobamateANDA 85720	Watson Labs	12	Discontinued
Jul 13, 1977	MeprobamateANDA 85721	Watson Labs	14	Discontinued
Mar 18, 1982	MeprobamateANDA 87825	Usl Pharma	0	Discontinued
Mar 18, 1982	MeprobamateANDA 87826	Usl Pharma	0	Discontinued
Jul 14, 1982	MeprobamateANDA 88011	Vangard	0	Discontinued
Nov 25, 1987	MeprobamateANDA 89538	Lee Km	1	Discontinued
Feb 27, 2008	MeprobamateANDA 40797	Invagen Pharms	0	Marketed
Feb 18, 2009	MeprobamateANDA 90122	Alembic Pharms Ltd	0	Marketed
May 23, 2011	MeprobamateANDA 200998	Taro	0	Discontinued
—	MeprospanNDA 11284	Medpointe Pharm Hlc	0	Discontinued
—	EquanilNDA 12455	Wyeth Ayerst	0	Discontinued
—	MeprobamateNDA 14322	Impax Labs	0	Discontinued
—	MeprobamateNDA 14368	Mk Labs	0	Discontinued
—	MeprobamateNDA 14474	Stanlabs Pharm	6	Discontinued
—	MeprobamateNDA 14601	Pvt Form	10	Discontinued
—	MeprobamateNDA 15139	Valeant Pharm Intl	0	Discontinued
—	MeprobamateNDA 15426	Elkins Sinn	0	Discontinued
—	MeprobamateNDA 15438	Ivax Sub Teva Pharms	0	Discontinued
—	MepriamNDA 16069	Teva	0	Discontinued
—	MeprobamateNDA 16928	Heather	0	Discontinued
—	MeprobamateANDA 84804	Purepac Pharm	0	Discontinued
—	MeprobamateANDA 83343	Scherer Labs	0	Discontinued
—	MeprobamateANDA 83494	Tablicaps	0	Discontinued
—	MeprobamateANDA 83618	Mylan	0	Discontinued
—	MeprobamateANDA 84329	Heather	0	Discontinued
—	MeprobamateANDA 84332	Roxane	0	Discontinued
—	TranmepANDA 84369	Solvay	0	Discontinued
—	MeprobamateANDA 84435	Solvay	0	Discontinued
—	MeprobamateANDA 84438	Pharmavite	0	Discontinued
—	MeprobamateANDA 84546	Perrigo	1	Discontinued
—	MeprobamateANDA 84547	Perrigo	3	Discontinued
—	MeprobamateANDA 86299	Lederle	0	Discontinued

Show all 57

Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA